2025 Program Committee

Kristen Albright, PharmD
CEO, Prokarium

Mara Aspinall
Partner, Illumina Ventures

Martha Azer
Associate Director, Global Regulatory Policy & Intelligence, Johnson & Johnson Innovative Medicine

Abi Barrow
Managing Partner, Cambridge Innovation Partners

Karen Boezi
Chief Operating Officer, Thirona Biosciences

Ted Buckley, PhD
Vice President, Government Affairs, Shionogi

Hemmie Chang
Boston Office Managing Partner, Arnold & Porter

Helena Chaye, PhD
CEO, KaliVir

Sadhana Chitale
Senior Director, Life Sciences, Technology Transfer, New York University Langone Health

Azurii K. Collier, Ph.D.
Director, AbbVie

Drew Cutshaw, MD
Principal, Pappas Capital

Dean Edelman
Life Science Lead for Corporate Engagement, Princeton

Greg Frank
Director, Global Public Policy, Merck & Co.

Elizabeth Franklin, PhD
Head, US Public Affairs and Patient Advocacy, Oncology, Sanofi

Joydeep Ganguly
Senior Vice President of Corporate Operations, and Chief Sustainability Officer, Gilead Sciences

Gail Gannon
Founding Director, Neurotech Collider Lab, University of California, Berkeley

Luba Greenwood
Managing Partner, Binney Street Capital

Troy Groetken
Shareholder, Board Member and Executive Committee Member, McAndrews, Held & Malloy, Ltd

Anjali Gupta, PhD
CEO & Co-founder, ANYg.BIO

Mary Haak-Frendscho, PhD
CEO, Spotlight Therapeutics

Susie Harborth
Chief Business Officer, Breakthrough Properties

Christina Hochul
Director, Government Affairs & Policy, Astellas Pharma

Amy House
Head of Portfolio Strategy, Beacon Therapeutics

Matthew Hudes
CEO, BdlBiologx

Ashley John
Director, Issue Advocacy, Novartis

Terrell Kingwood
Operations Manager - Strategic Operations, Health Equity & Organizational Health, Genentech

Ravi Kiron
Managing Director, Biopharm Strategy

Andrew Lam, PharmD
Managing Director, Head of Biotech Private Equity, Ally Bridge Group

Gabriela Lavezzari, PhD, MBA
Head of Digital Transformation & Innovation, GSK

Chris LeMasters
CEO, XinThera, a Gilead Company

Michelle Linn
Founder & CEO, Linnden Communications

Andrew McCandlish
COO, Revagenix, Inc.

Janet McNicholas, PhD
Chief Legal Officer, Invenra Inc.

Snehal Naik, PhD
Head of Regulatory Policy and Content Management, Spark Therapeutics

Kevin Noonan
Partner, McDonnell Boehnen Hulbert & Berghoff LLP

Daryl Pritchard, PhD
Senior Vice President, Policy and Government Affairs, Personalized Medicine Coalition

Suguna Rachakonda
VP, Head of Business Development, Dewpoint Therapeutics

Jim Schaeffer
Chief Business Officer, PhenoTarget Biosciences

Liz Schwarzbach
Chief Business Officer, BigHat Biosciences

Maude Tessier, PhD
Chief Business Officer, Seismic Therapeutic

Pam Traxel
Senior Vice President, American Cancer Society Cancer Action Network, Inc.

Arda Ural, PhD
Americas Life Sciences Sector Leader, EY (Ernst & Young)

Amy Walker, PhD
Director, US Policy & Advocacy, CSL Seqirus

Hanadie Yousef, PhD
CEO and co-founder, Juvena Therapeutics